- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Opioid dependence
- Meeting Date: December 2020
- Public Summary Document (PSD) September 2020 PBAC Meeting - (PDF 569KB)
- Public Summary Document (PSD) September 2020 PBAC Meeting - (Word 26KB)
Nurse Practitioners as Secondary Reviewers for Ongoing Treatment with Opioid Medications - December 2020
Nurse Practitioners as Secondary Reviewers for Ongoing Treatment with Opioid Medications
Last updated
8 July 2025